StreetAlpha.app
Home › Stocks › TAK

Takeda Pharmaceutical Co Ltd (TAK)

Healthcare
$21.64
▲ +0.23%
LAST CLOSE · NOV 17

Takeda makes and sells branded prescription medicines, selling to hospitals, insurers and government health programs in Japan, the U.S. and Europe. It last closed at $21.64 on Nov 17, up 0.23% on the day. TAK reports earnings on Thu, Jan 28, 2027.

AI Auto Pilots
Is TAK in one of our four AI portfolios? Sign in free to see

Key Stats

Fiscal 2025
Results
Revenue
JPY 4.58T
+7.5% vs a year ago
Net income
JPY 108B
−25.1% vs a year ago
Free cash flow
JPY 856B
18.7% margin
Operating margin
7.5%
JPY 343B operating income
Balance sheet
Cash & equivalents
JPY 385B
At Mar 31
Debt
JPY 4.52T
At Mar 31
Shareholder equity
JPY 6.94T
ExchangeNYSE
Financials history
FY2021: JPY 3.20TJPY 3.20TFY2021FY2022: JPY 3.57TJPY 3.57TFY2022FY2023: JPY 4.03TJPY 4.03TFY2023FY2024: JPY 4.26TJPY 4.26TFY2024FY2025: JPY 4.58TJPY 4.58TFY2025

From TAK's SEC filings, latest 20-F for the period ending Mar 31, 2025 (filed Jun 17). Figures are in JPY. Per share figures are left out because the US listing can represent a different number of shares.

Next report
Jan 28
2027 · Time not announced
Consensus EPS forecast
$0.14
$7.49B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
—
No ratings in 90 days
Loading…

Technical Analysis

TAK · as of the Nov 17 close · updated after every close
Uptrend, overbought

The stock is 4% above its 20 day and 10% above its 50 day average. It is 18% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 73), overbought. The nearest support is the Pivot at $21.62, and the nearest resistance the swing high (Nov 5) at $21.73.

Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityHigh, 1.9%/day
Key levels
$21.8652 week high+1.0%
$21.76Pivot R1+0.6%
$21.73Swing high (Nov 5)+0.4%
$21.64Last close
$21.62Pivot−0.1%
$21.51Pivot S1−0.6%
$20.7920 day average−3.9%
$20.62Swing low (Nov 6)−4.7%
$19.5350 day average−9.8%
$18.43100 day average−14.8%
$17.82200 day average−17.7%
$13.9152 week low−35.7%
Indicators
RSI (14)72.58Overbought above 70Overbought
MACD0.58Above its signal lineBullish
Stochastic88.8Near the top of its rangeOverbought
ADX (14)33.1Trending up
Williams %R-8.9Oversold below −80, overbought above −20Overbought
CCI (20)129.2Oversold below −100, overbought above 100Overbought
Rate of change+4.3%Change over 10 sessionsBullish
ATR (14)$0.41Typical daily range, 1.9% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for TAK

What happened before

See how TAK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow TAK usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How TAK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2008.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in TAK in the last 90 days.

Loading…

See today’s whale options flow across the market →

TAK Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲233 buying vs 130 selling
  • ▲Shares held by funds +16.8%
  • ▲Funds holding +16
  • ▲Superinvestors: 4 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding396380+4.2%
In funds' top 1021+100.0%
Held by funds–––
New / increased60 / 17361 / 146+12.6%
Reduced / sold out90 / 40100 / 42−8.5%
Put/call ratio0.080.31−72.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TAK institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TAK is in one of them and how their past TAK trades turned out.

TAK in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TAK in an article yet. Here's the latest on the wider market.

TAK Congress Trades

All congress trades →
Trades, 12 months
2
Buys
2
100%
Sells
0
0%
People
2
Last filed Nov 5
Who traded TAK · since 2018
Latest 5 filings of 14
$1K – $15KTraded Oct 9, 2026Filed Nov 5, 2026
$1K – $15KTraded Mar 30, 2026Filed Jul 21, 2026
$1K – $15KTraded May 9, 2025Filed Jun 12, 2025
$1K – $15KTraded Mar 14, 2025Filed Apr 11, 2025
$15K – $50KTraded Aug 29, 2023Filed Sep 5, 2023
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KOct 9, 2026Nov 5, 202627 d
Alan ArmstrongHouseBuy$1K – $15KMar 30, 2026Jul 21, 2026113 d
Ro KhannaD · CASell$1K – $15KMay 9, 2025Jun 12, 202534 d
Ro KhannaD · CABuy$1K – $15KMar 14, 2025Apr 11, 202528 d
Virginia FoxxR · NCSell$15K – $50KAug 29, 2023Sep 5, 20237 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Takeda Pharmaceutical Co

Takeda is a pharmaceutical company based in Tokyo, Japan, that makes and sells branded prescription medicines. Its products are sold in the United States, Europe, Japan and emerging markets such as China. Its customers include hospitals and medical institutions, insurers and managed care groups, pharmacy benefit managers, and government health programs. Its products face price pressure and competition from generic and biosimilar versions once patent or regulatory protection ends.

Headquarters
Tokyo, Japan